Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000018

COFO and Secretary sold 10,000 shares at an average $29.53 ($295,339)

  • COFO and Secretary acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COFO and Secretary

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-17 Exercise or conversion : show line 1 in the form +10,000 $5.28 $52,800 507,173 I
2023-01-17 Sale : show line 2 in the form −9,886 $29.53 $291,934 497,287 I
2023-01-17 Sale : show line 3 in the form −114 $29.87 $3,405 497,173 I
Open-market sales · 10,000 sh · avg $29.53 · $295,339

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-17 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −10,000 98,937 D
Loading xslF345X03/wf-form4_167416615634275.xml…